Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Filings indexed 1,418 across all filing types
Latest filing 2020-03-23 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings'. It details changes in the percentage of voting rights held by a specific legal entity (AIM INTERNATIONAL MUTUAL FUNDS) in MorphoSys AG, referencing German Securities Trading Act (WpHG) sections (Article 40, Sec. 33, 34, 38). This content directly corresponds to reporting changes in significant share ownership thresholds, which aligns perfectly with the definition for Major Shareholding Notification (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the core content is the change in holding percentage, making MRQ more specific than DVA (Declaration of Voting Results) or RNS (General Regulatory Filing).
2020-03-23 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables regarding the 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in the percentage of voting rights held by FMR LLC and its controlled entities, crossing specific thresholds (Section 6 and 7). This directly corresponds to the definition of a major shareholding notification, which in the provided schema maps to 'Major Shareholding Notification' (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a formal disclosure of ownership change, fitting MRQ better than DVA (which is for voting results) or RNS (which is a fallback).
2020-03-19 English
MorphoSys Presents Results for Fiscal Year 2019 (news with additional features)
Earnings Release Classification · 1% confidence The document is an official announcement from MorphoSys AG regarding their financial results for the fiscal year 2019. It contains key financial highlights, a detailed financial review, and future guidance. While it provides significant financial data, it is structured as a press release (DGAP-News) rather than the full, audited Annual Report (10-K). It serves as the initial public communication of the annual performance, which fits the definition of an Earnings Release (ER). FY 2019
2020-03-18 English
Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal announcement titled 'Total Voting Rights Announcement' from MorphoSys AG, referencing Article 41 of the WpHG (German Securities Trading Act). It explicitly details a 'Type of capital measure' involving a 'Conditional capital increase' and reports the 'New total number of voting rights' as 32,890,046 as of March 13, 2020. This content directly relates to changes in the company's capital structure and share count, which aligns best with the 'Share Issue/Capital Change' definition (SHA). It is not a general earnings release (ER), a full annual report (10-K), or a management change announcement (MANG).
2020-03-13 English
Invitation to MorphoSys' Year-End Results 2019 Conference Call on March 19, 2020 (news with additional features)
Report Publication Announcement Classification · 1% confidence The document is a news release dated March 12, 2020, titled "Invitation to MorphoSys’ Year-End Results 2019 Conference Call on March 19, 2020". It explicitly states that the company will publish its Year-End Results 2019 on March 18, 2020, and then invites participants to a conference call/webcast on March 19, 2020, to present those results. Since the document's primary purpose is to announce the upcoming presentation of results (the conference call) rather than being the full results document itself (like a 10-K or ER), and it is a short news item announcing the event, it fits the definition of a Report Publication Announcement (RPA). It is announcing the publication/discussion of the annual results, but it is not the annual report itself.
2020-03-12 English
Declaration of Voting Results & Voting Rights Announcements 2020
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. It details changes in voting rights percentages held by BlackRock, Inc. (crossing a threshold) and provides the date the threshold was crossed (27 Feb 2020). This content directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2020-03-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.